“Harnessing AI for treatment optimization: Neoadjuvant chemotherapy in gastroesophageal cancer"-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

“Harnessing AI for treatment optimization: Neoadjuvant chemotherapy in gastroesophageal cancer"

Published:2024-04 Issue:4 Volume:50 Page:108228
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology
language:en
Short-container-title:European Journal of Surgical Oncology

Author:

Sheen Abdullah Rizwan^ORCID,Saqib Hasnain Wajeeh us^ORCID

Publisher

Elsevier BV

Reference4 articles.

1. Survival and complications after neoadjuvant chemotherapy or chemoradiotherapy for esophageal cancer: a meta-analysis;Han;Future Oncol,2021

2. Effects of neoadjuvant therapy on health-related quality of life for patients with gastroesophageal cancer;Holmén;Eur J Surg Oncol,2023

3. Predicting response of triple-negative breast cancer to neoadjuvant chemotherapy using a Deep convolutional neural network–based artificial intelligence tool;Krishnamurthy;JCO Clin Cancer Inform,2023

4. Analysis of tumor nuclear features using artificial intelligence to predict response to neoadjuvant chemotherapy in high-risk breast cancer patients;Dodington;Breast Cancer Res Treat,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP